価格表

在庫・価格 : 2025年05月07日 01時12分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
IL-33, Mouse, Recombinant
データシート
3626-ML-010 RSDアールアンドディー システムズ
R&D Systems, Inc.
10 μg ¥90,000 3個以上 追加

在庫・価格 : 2025年05月07日 01時12分 現在

IL-33, Mouse, Recombinant

  • 商品コード:3626-ML-010
  • メーカー:RSD
  • 包装:10μg
  • 価格: ¥90,000
  • 在庫:3個以上
使用文献
No. 文献情報 備考 参照
1 Palmer G et al. The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33. Cytokine 2008 Jun;42(3):358-64
Palmer G et al
2008/01/01
Species: Mouse, Application: Bioassay, protein PubMed
2 Hudson CA et al. Induction of IL-33 expression and activity in central nervous system glia. J. Leukoc. Biol. 2008 Sep;84(3):631-43
Hudson CA et al
2008/01/01
Species: Mouse, Application: Bioassay, ELISA Standard, Whole Cells PubMed
3 Palmer G et al. Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. Arthritis Rheum. 2009 Mar;60(3):738-49
Palmer G et al
2009/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
4 Bourgeois E et al. The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production. Eur. J. Immunol. 2009 Apr;39(4):1046-55
Bourgeois E et al
2009/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
5 Perrigoue JG et al. MHC class II-dependent basophil-CD4+ T cell interactions promote T(H)2 cytokine-dependent immunity. Nat. Immunol. 2009 Jul;10(7):697-705
Perrigoue JG et al
2009/01/01
Application: In Vivo PubMed
6 Ohno T et al. Caspase-1, caspase-8, and calpain are dispensable for IL-33 release by macrophages. J. Immunol. 2009 Dec;183(12):7890-7
Ohno T et al
2009/01/01
Application: Cell Culture Substrate,ELISA Standard, Sample Type: Cell Supernates,Whole Cells PubMed
7 Neill DR et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010 Apr;464(7293):1367-70
Neill DR et al
2010/01/01
Application: In Vivo, Sample Type: In Vivo PubMed
8 Price AE et al. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc. Natl. Acad. Sci. U.S.A. 2010 Jun;107(25):11489-94
Price AE et al
2010/01/01
Application: In Vivo, Sample Type: In Vivo PubMed
9 Kayamuro H et al. Interleukin-1 family cytokines as mucosal vaccine adjuvants for induction of protective immunity against influenza virus. J. Virol. 2010 Dec;84(24):12703-12
Kayamuro H et al
2010/01/01
Application: In Vivo, Sample Type: In Vivo PubMed
10 Bourgeois EA et al. A natural protective function of invariant NKT cells in a mouse model of innate-cell-driven lung inflammation. Eur. J. Immunol. 2011 Feb;41(2):299-305
Bourgeois EA et al
2011/01/01
Application: In Vivo PubMed
11 Yasuoka S et al. Production and functions of IL-33 in the central nervous system. Brain Res. 2011 Apr;1385:8-17
Yasuoka S et al
2011/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
12 Louten J et al. Endogenous IL-33 enhances Th2 cytokine production and T-cell responses during allergic airway inflammation. Int. Immunol. 2011 May;23(5):307-15
Louten J et al
2011/01/01
Application: In Vivo, Sample Type: In Vivo PubMed
13 Besnard AG et al. IL-33-activated dendritic cells are critical for allergic airway inflammation. Eur. J. Immunol. 2011 Jun;41(6):1675-86
Besnard AG et al
2011/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
14 Anthony RM et al. Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway. Nature 2011 Jul;475(7354):110-3
Anthony RM et al
2011/01/01
Application: In Vivo, Sample Type: In Vivo PubMed
15 Monticelli LA et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat. Immunol. 2011 Nov;12(11):1045-54
Monticelli LA et al
2011/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
16 Brickshawana A et al. Lineage(-)Sca1+c-Kit(-)CD25+ cells are IL-33-responsive type 2 innate cells in the mouse bone marrow. J. Immunol. 2011 Dec;187(11):5795-804
Brickshawana A et al
2011/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
17 Bartemes KR et al. IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs. J. Immunol. 2012 Feb;188(3):1503-13
Bartemes KR et al
2012/01/01
Application: Bioassay,In Vivo, Sample Type: In Vivo,Whole Cells PubMed
18 Casey KA et al. Antigen-independent differentiation and maintenance of effector-like resident memory T cells in tissues. J. Immunol. 2012 May;188(10):4866-75
Casey KA et al
2012/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
19 Klein Wolterink RG et al. Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma. Eur. J. Immunol. 2012 May;42(5):1106-16
Klein Wolterink RG et al
2012/01/01
Application: In Vivo, Sample Type: In Vivo PubMed
20 Freeman BE et al. Regulation of innate CD8+ T-cell activation mediated by cytokines. Proc. Natl. Acad. Sci. U.S.A. 2012 Jun;109(25):9971-6
Freeman BE et al
2012/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
21 Kaieda S et al. Interleukin-33 primes mast cells for activation by IgG immune complexes. PLoS ONE 2012;7(10):e47252
Kaieda S et al
2012/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
22 Willart MA et al. Interleukin-1α controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33. J. Exp. Med. 2012 Jul;209(8):1505-17
Willart MA et al
2012/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
23 Mizutani N et al. Interleukin-33 and alveolar macrophages contribute to the mechanisms underlying the exacerbation of IgE-mediated airway inflammation and remodelling in mice. Immunology 2013 Jun;139(2):205-18
Mizutani N et al
2013/01/01
Application: In Vivo, Sample Type: In Vivo PubMed
24 Sandig H et al. IL-33 causes selective mast cell tolerance to bacterial cell wall products by inducing IRAK1 degradation. Eur. J. Immunol. 2013 Apr;43(4):979-88
Sandig H et al
2013/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
25 Yang Z et al. Macrophages as IL-25/IL-33-responsive cells play an important role in the induction of type 2 immunity. PLoS ONE 2013;8(3):e59441
Yang Z et al
2013/01/01
Application: In vivo injection, Sample Type: In Vivo PubMed
26 Tung HY et al. Murine mast cells secrete and respond to interleukin-33. J. Interferon Cytokine Res. 2014 Mar;34(3):141-7
Tung HY et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
27 Gao Y et al. Control of T helper 2 responses by transcription factor IRF4-dependent dendritic cells. Immunity 2013 Oct;39(4):722-32
Gao Y et al
2013/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
28 Jovanovic IP et al. Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells. Int. J. Cancer 2014 Apr;134(7):1669-82
Jovanovic IP et al
2014/01/01
Application: In vivo injection, Sample Type: In Vivo PubMed
29 Palm NW et al. Bee venom phospholipase A2 induces a primary type 2 response that is dependent on the receptor ST2 and confers protective immunity. Immunity 2013 Nov;39(5):976-85
Palm NW et al
2013/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
30 Yu X et al. TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers. Mucosal Immunol 2014 May;7(3):730-40
Yu X et al
2014/01/01
Application: In vivo injection, Sample Type: In Vivo PubMed
31 Khattar M et al. Interleukin-21 is a critical regulator of CD4 and CD8 T cell survival during priming under Interleukin-2 deprivation conditions. PLoS ONE 2014;9(1):e85882
Khattar M et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
32 McSorley HJ et al. Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy. Mucosal Immunol 2014 Sep;7(5):1068-78
McSorley HJ et al
2014/01/01
Application: In Vivo, Sample Type: In Vivo PubMed
33 Rizvi S et al. Platelet-derived growth factor primes cancer-associated fibroblasts for apoptosis. J. Biol. Chem. 2014 Aug;289(33):22835-49
Rizvi S et al
2014/01/01
Application: In Vivo, Sample Type: Whole Organism PubMed
34 Huang Y et al. IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential 'inflammatory' type 2 innate lymphoid cells. Nat. Immunol. 2015 Feb;16(2):161-9
Huang Y et al
2015/01/01
Application: In vivo injection, Sample Type: Whole Organism PubMed
35 Brestoff JR et al. Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature 2014 Dec;
Brestoff JR et al
2014/01/01
Application: In Vivo, Sample Type: In Vivo PubMed
36 Vasanthakumar A et al. The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells. Nat. Immunol. 2015 Mar;16(3):276-85
Vasanthakumar A et al
2015/01/01
Application: In vivo injection, Sample Type: In Vivo PubMed
37 Yamada KJ et al. Eosinophil-associated ribonuclease 11 is a macrophage chemoattractant. J. Biol. Chem. 2015 Apr;290(14):8863-75
Yamada KJ et al
2015/01/01
Application: In Vivo, Sample Type: In Vivo PubMed
38 Hara K et al. Airway uric acid is a sensor of inhaled protease allergens and initiates type 2 immune responses in respiratory mucosa. J. Immunol. 2014 May;192(9):4032-42
Hara K et al
2014/01/01
Application: In Vivo, Sample Type: In Vivo PubMed
39 Nabekura T et al. IL-33 receptor ST2 amplifies the expansion of NK cells and enhances host defense during mouse cytomegalovirus infection. J. Immunol. 2015 Jun;194(12):5948-52
Nabekura T et al
2015/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
40 Kempuraj D et al. Dopaminergic Toxin 1-Methyl-4-Phenylpyridinium, Proteins α-Synuclein and Glia Maturation Factor Activate Mast Cells and Release Inflammatory Mediators. PLoS ONE 2015;10(8):e0135776
Kempuraj D et al
2015/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
41 Monticelli LA et al. IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions. Proc. Natl. Acad. Sci. U.S.A. 2015 Aug;112(34):10762-7
Monticelli LA et al
2015/01/01
Application: In Vivo, Sample Type: In Vivo PubMed
42 Ibiza S et al. Glial-cell-derived neuroregulators control type 3 innate lymphoid cells and gut defence. Nature 2016 Jul;535(7612):440-3
Ibiza S et al
2016/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
43 Peng H et al. IL-33 Contributes to Schistosoma japonicum-induced Hepatic Pathology through Induction of M2 Macrophages. Sci Rep 2016 Jul;6:29844
Peng H et al
2016/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
44 Biton J et al. In Vivo Expansion of Activated Foxp3+ Regulatory T Cells and Establishment of a Type 2 Immune Response upon IL-33 Treatment Protect against Experimental Arthritis. J. Immunol. 2016 Sep;197(5):1708-19
Biton J et al
2016/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
45 Liu B et al. IL-33/ST2 signaling excites sensory neurons and mediates itch response in a mouse model of poison ivy contact allergy. Proc. Natl. Acad. Sci. U.S.A. 2016 Nov;113(47):E7572-E7579
Liu B et al
2016/01/01
Application: In vivo, Sample Type: In Vivo PubMed
46 Sektioglu IM et al. Basophils Promote Tumor Rejection via Chemotaxis and Infiltration of CD8+ T Cells. Cancer Res. 2017 Jan;77(2):291-302
Sektioglu IM et al
2017/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
47 Lap辿rine O et al. Interleukin-33 and RANK-L Interplay in the Alveolar Bone Loss Associated to Periodontitis. PLoS ONE 2016;11(12):e0168080
Lap辿rine O et al
2016/01/01
Application: Bioassay, Sample Type: Whole Tissue PubMed
48 Tan Z et al. Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells. Cell. Mol. Immunol. 2017 Feb;
Tan Z et al
2017/01/01
Application: In Vivo, Sample Type: In Vivo PubMed
49 Abad M et al. Notch Inhibition Enhances Cardiac Reprogramming by Increasing MEF2C Transcriptional Activity. Stem Cell Reports 2017 Mar;8(3):548-560
Abad M et al
2017/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
50 Bi J et al. NK Cells Alleviate Lung Inflammation by Negatively Regulating Group 2 Innate Lymphoid Cells. J. Immunol. 2017 Apr;198(8):3336-3344
Bi J et al
2017/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
51 Ikutani M et al. Prolonged activation of IL-5-producing ILC2 causes pulmonary arterial hypertrophy. JCI Insight 2017 Apr;2(7):e90721
Ikutani M et al
2017/01/01
Application: In Vivo, Sample Type: In Vivo PubMed
52 Sezaki T et al. Disruption of the TWEAK/Fn14 pathway prevents 5-fluorouracil-induced diarrhea in mice. World J. Gastroenterol. 2017 Apr;23(13):2294-2307
Sezaki T et al
2017/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
  • No.: 1
  • 文献情報:
    Palmer G et al. The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33. Cytokine 2008 Jun;42(3):358-64
    Palmer G et al
    2008/01/01
  • 備考:
    Species: Mouse, Application: Bioassay, protein
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Hudson CA et al. Induction of IL-33 expression and activity in central nervous system glia. J. Leukoc. Biol. 2008 Sep;84(3):631-43
    Hudson CA et al
    2008/01/01
  • 備考:
    Species: Mouse, Application: Bioassay, ELISA Standard, Whole Cells
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Palmer G et al. Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. Arthritis Rheum. 2009 Mar;60(3):738-49
    Palmer G et al
    2009/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Bourgeois E et al. The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production. Eur. J. Immunol. 2009 Apr;39(4):1046-55
    Bourgeois E et al
    2009/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Perrigoue JG et al. MHC class II-dependent basophil-CD4+ T cell interactions promote T(H)2 cytokine-dependent immunity. Nat. Immunol. 2009 Jul;10(7):697-705
    Perrigoue JG et al
    2009/01/01
  • 備考:
    Application: In Vivo
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Ohno T et al. Caspase-1, caspase-8, and calpain are dispensable for IL-33 release by macrophages. J. Immunol. 2009 Dec;183(12):7890-7
    Ohno T et al
    2009/01/01
  • 備考:
    Application: Cell Culture Substrate,ELISA Standard, Sample Type: Cell Supernates,Whole Cells
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Neill DR et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010 Apr;464(7293):1367-70
    Neill DR et al
    2010/01/01
  • 備考:
    Application: In Vivo, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Price AE et al. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc. Natl. Acad. Sci. U.S.A. 2010 Jun;107(25):11489-94
    Price AE et al
    2010/01/01
  • 備考:
    Application: In Vivo, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Kayamuro H et al. Interleukin-1 family cytokines as mucosal vaccine adjuvants for induction of protective immunity against influenza virus. J. Virol. 2010 Dec;84(24):12703-12
    Kayamuro H et al
    2010/01/01
  • 備考:
    Application: In Vivo, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Bourgeois EA et al. A natural protective function of invariant NKT cells in a mouse model of innate-cell-driven lung inflammation. Eur. J. Immunol. 2011 Feb;41(2):299-305
    Bourgeois EA et al
    2011/01/01
  • 備考:
    Application: In Vivo
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Yasuoka S et al. Production and functions of IL-33 in the central nervous system. Brain Res. 2011 Apr;1385:8-17
    Yasuoka S et al
    2011/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Louten J et al. Endogenous IL-33 enhances Th2 cytokine production and T-cell responses during allergic airway inflammation. Int. Immunol. 2011 May;23(5):307-15
    Louten J et al
    2011/01/01
  • 備考:
    Application: In Vivo, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Besnard AG et al. IL-33-activated dendritic cells are critical for allergic airway inflammation. Eur. J. Immunol. 2011 Jun;41(6):1675-86
    Besnard AG et al
    2011/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Anthony RM et al. Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway. Nature 2011 Jul;475(7354):110-3
    Anthony RM et al
    2011/01/01
  • 備考:
    Application: In Vivo, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Monticelli LA et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat. Immunol. 2011 Nov;12(11):1045-54
    Monticelli LA et al
    2011/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Brickshawana A et al. Lineage(-)Sca1+c-Kit(-)CD25+ cells are IL-33-responsive type 2 innate cells in the mouse bone marrow. J. Immunol. 2011 Dec;187(11):5795-804
    Brickshawana A et al
    2011/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Bartemes KR et al. IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs. J. Immunol. 2012 Feb;188(3):1503-13
    Bartemes KR et al
    2012/01/01
  • 備考:
    Application: Bioassay,In Vivo, Sample Type: In Vivo,Whole Cells
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Casey KA et al. Antigen-independent differentiation and maintenance of effector-like resident memory T cells in tissues. J. Immunol. 2012 May;188(10):4866-75
    Casey KA et al
    2012/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Klein Wolterink RG et al. Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma. Eur. J. Immunol. 2012 May;42(5):1106-16
    Klein Wolterink RG et al
    2012/01/01
  • 備考:
    Application: In Vivo, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Freeman BE et al. Regulation of innate CD8+ T-cell activation mediated by cytokines. Proc. Natl. Acad. Sci. U.S.A. 2012 Jun;109(25):9971-6
    Freeman BE et al
    2012/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Kaieda S et al. Interleukin-33 primes mast cells for activation by IgG immune complexes. PLoS ONE 2012;7(10):e47252
    Kaieda S et al
    2012/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Willart MA et al. Interleukin-1α controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33. J. Exp. Med. 2012 Jul;209(8):1505-17
    Willart MA et al
    2012/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Mizutani N et al. Interleukin-33 and alveolar macrophages contribute to the mechanisms underlying the exacerbation of IgE-mediated airway inflammation and remodelling in mice. Immunology 2013 Jun;139(2):205-18
    Mizutani N et al
    2013/01/01
  • 備考:
    Application: In Vivo, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Sandig H et al. IL-33 causes selective mast cell tolerance to bacterial cell wall products by inducing IRAK1 degradation. Eur. J. Immunol. 2013 Apr;43(4):979-88
    Sandig H et al
    2013/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Yang Z et al. Macrophages as IL-25/IL-33-responsive cells play an important role in the induction of type 2 immunity. PLoS ONE 2013;8(3):e59441
    Yang Z et al
    2013/01/01
  • 備考:
    Application: In vivo injection, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Tung HY et al. Murine mast cells secrete and respond to interleukin-33. J. Interferon Cytokine Res. 2014 Mar;34(3):141-7
    Tung HY et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Gao Y et al. Control of T helper 2 responses by transcription factor IRF4-dependent dendritic cells. Immunity 2013 Oct;39(4):722-32
    Gao Y et al
    2013/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Jovanovic IP et al. Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells. Int. J. Cancer 2014 Apr;134(7):1669-82
    Jovanovic IP et al
    2014/01/01
  • 備考:
    Application: In vivo injection, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Palm NW et al. Bee venom phospholipase A2 induces a primary type 2 response that is dependent on the receptor ST2 and confers protective immunity. Immunity 2013 Nov;39(5):976-85
    Palm NW et al
    2013/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Yu X et al. TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers. Mucosal Immunol 2014 May;7(3):730-40
    Yu X et al
    2014/01/01
  • 備考:
    Application: In vivo injection, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Khattar M et al. Interleukin-21 is a critical regulator of CD4 and CD8 T cell survival during priming under Interleukin-2 deprivation conditions. PLoS ONE 2014;9(1):e85882
    Khattar M et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    McSorley HJ et al. Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy. Mucosal Immunol 2014 Sep;7(5):1068-78
    McSorley HJ et al
    2014/01/01
  • 備考:
    Application: In Vivo, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Rizvi S et al. Platelet-derived growth factor primes cancer-associated fibroblasts for apoptosis. J. Biol. Chem. 2014 Aug;289(33):22835-49
    Rizvi S et al
    2014/01/01
  • 備考:
    Application: In Vivo, Sample Type: Whole Organism
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Huang Y et al. IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential 'inflammatory' type 2 innate lymphoid cells. Nat. Immunol. 2015 Feb;16(2):161-9
    Huang Y et al
    2015/01/01
  • 備考:
    Application: In vivo injection, Sample Type: Whole Organism
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Brestoff JR et al. Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature 2014 Dec;
    Brestoff JR et al
    2014/01/01
  • 備考:
    Application: In Vivo, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Vasanthakumar A et al. The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells. Nat. Immunol. 2015 Mar;16(3):276-85
    Vasanthakumar A et al
    2015/01/01
  • 備考:
    Application: In vivo injection, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Yamada KJ et al. Eosinophil-associated ribonuclease 11 is a macrophage chemoattractant. J. Biol. Chem. 2015 Apr;290(14):8863-75
    Yamada KJ et al
    2015/01/01
  • 備考:
    Application: In Vivo, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Hara K et al. Airway uric acid is a sensor of inhaled protease allergens and initiates type 2 immune responses in respiratory mucosa. J. Immunol. 2014 May;192(9):4032-42
    Hara K et al
    2014/01/01
  • 備考:
    Application: In Vivo, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Nabekura T et al. IL-33 receptor ST2 amplifies the expansion of NK cells and enhances host defense during mouse cytomegalovirus infection. J. Immunol. 2015 Jun;194(12):5948-52
    Nabekura T et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Kempuraj D et al. Dopaminergic Toxin 1-Methyl-4-Phenylpyridinium, Proteins α-Synuclein and Glia Maturation Factor Activate Mast Cells and Release Inflammatory Mediators. PLoS ONE 2015;10(8):e0135776
    Kempuraj D et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Monticelli LA et al. IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions. Proc. Natl. Acad. Sci. U.S.A. 2015 Aug;112(34):10762-7
    Monticelli LA et al
    2015/01/01
  • 備考:
    Application: In Vivo, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    Ibiza S et al. Glial-cell-derived neuroregulators control type 3 innate lymphoid cells and gut defence. Nature 2016 Jul;535(7612):440-3
    Ibiza S et al
    2016/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    Peng H et al. IL-33 Contributes to Schistosoma japonicum-induced Hepatic Pathology through Induction of M2 Macrophages. Sci Rep 2016 Jul;6:29844
    Peng H et al
    2016/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    Biton J et al. In Vivo Expansion of Activated Foxp3+ Regulatory T Cells and Establishment of a Type 2 Immune Response upon IL-33 Treatment Protect against Experimental Arthritis. J. Immunol. 2016 Sep;197(5):1708-19
    Biton J et al
    2016/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 45
  • 文献情報:
    Liu B et al. IL-33/ST2 signaling excites sensory neurons and mediates itch response in a mouse model of poison ivy contact allergy. Proc. Natl. Acad. Sci. U.S.A. 2016 Nov;113(47):E7572-E7579
    Liu B et al
    2016/01/01
  • 備考:
    Application: In vivo, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 46
  • 文献情報:
    Sektioglu IM et al. Basophils Promote Tumor Rejection via Chemotaxis and Infiltration of CD8+ T Cells. Cancer Res. 2017 Jan;77(2):291-302
    Sektioglu IM et al
    2017/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 47
  • 文献情報:
    Lap辿rine O et al. Interleukin-33 and RANK-L Interplay in the Alveolar Bone Loss Associated to Periodontitis. PLoS ONE 2016;11(12):e0168080
    Lap辿rine O et al
    2016/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 48
  • 文献情報:
    Tan Z et al. Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells. Cell. Mol. Immunol. 2017 Feb;
    Tan Z et al
    2017/01/01
  • 備考:
    Application: In Vivo, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 49
  • 文献情報:
    Abad M et al. Notch Inhibition Enhances Cardiac Reprogramming by Increasing MEF2C Transcriptional Activity. Stem Cell Reports 2017 Mar;8(3):548-560
    Abad M et al
    2017/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 50
  • 文献情報:
    Bi J et al. NK Cells Alleviate Lung Inflammation by Negatively Regulating Group 2 Innate Lymphoid Cells. J. Immunol. 2017 Apr;198(8):3336-3344
    Bi J et al
    2017/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 51
  • 文献情報:
    Ikutani M et al. Prolonged activation of IL-5-producing ILC2 causes pulmonary arterial hypertrophy. JCI Insight 2017 Apr;2(7):e90721
    Ikutani M et al
    2017/01/01
  • 備考:
    Application: In Vivo, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 52
  • 文献情報:
    Sezaki T et al. Disruption of the TWEAK/Fn14 pathway prevents 5-fluorouracil-induced diarrhea in mice. World J. Gastroenterol. 2017 Apr;23(13):2294-2307
    Sezaki T et al
    2017/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed